lpcn1148; testosterone; cirrhosis; sarcopenia

https://www.lipocine.com/news-article/fda-grants-fast-track-designation-to-lipocine-for-lpcn-1148-as-a-treatment-for-sarcopenia-in-patients-with-decompensated-cirrhosis/ SALT LAKE CITY, Dec. 17, 2024 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its...